Progress in research on herpes simplex virus type 2 vaccine

Xiaohuan Zhang, Leitai Shi


Herpes simplex virus type 2 (HSV-2) belongs to the herpesvirus alpha herpesvirus family, which mainly causes genital infection. HSV-2 infection can also increase the risk of HIV infection. The use of condoms and antiviral treatment can reduce the infection rate of HSV-2, but can not fundamentally prevent the spread of the virus. Vaccination is an effective method, but no safe and reliable HSV-2 vaccine has been successfully marketed. This article will review the research status and progress of all kinds of HSV-2 vaccines.


Herpes simplex virus type 2; infection; Vaccine;

Full Text:



  • There are currently no refbacks.

Copyright (c) 2018 Journal of Applied Virology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.